NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Xeos

Xeos

Private
BelgiumHealthcare & Life Scienceshttps://xeos.care/

Last Round

Accelerator

May 27, 2026

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Xeos is a medical technology company that develops intraoperative molecular imaging solutions, including the AURA 10 PET-CT specimen imager, to improve surgical oncology outcomes.

Sector

Healthcare & Life Sciences

Verticals

Medical Imaging, Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Application

Keywords

intraoperative imagingsurgical oncologyPET-CTmedical imagingsurgical margin assessmentmolecular imagingmedical devicespecimen imagingintraoperative pathologyoperating room technologytumor margin analysisdigital pathologyAI-assisted surgerysurgical navigation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Xeos Comparables

Compare Xeos with similar companies based on industry and business-model similarity.

Xeos comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
SamanTree Medical
85%
KUBTEC Medical Imaging
81%
Perimeter Medical Imaging AI Inc
80%

Xeos Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorMay 27, 2026
VC RoundJan 9, 2026
GrantMar 20, 2024
VC RoundJan 13, 2020

Key People

Founding team and executive leadership

Vincent Keereman

Founder And CEO

Founding Team

Jakob Roelandt

CTO

Executive Team

Eva Roos

Chief Operating Officer

Executive Team

Xeos Investors

Notable investors and investment history

Xeos investors
InvestorRounds
MedTech InnovatorAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 27, 2026

    Received funding from MedTech Innovator.

Xeos Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Xeos Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Xeos's valuation, stock price, and market status.

Firmographic Details

HeadquartersBelgium
Employee Range31
Year Founded2019
Last FundingMay 27, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.